Published in Biometrics on June 01, 1985
Study of Rebamipide Eye Drops to Treat Dry Eye | NCT00201981
A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc (2009) 5.81
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol (2010) 4.81
Statistical aspects of prognostic factor studies in oncology. Br J Cancer (1994) 4.22
A robust method for estimating optimal treatment regimes. Biometrics (2012) 3.76
Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer. J Clin Oncol (2011) 3.46
Subgroup identification from randomized clinical trial data. Stat Med (2011) 3.22
Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial. Lancet Oncol (2012) 2.65
Age-related crossover in breast cancer incidence rates between black and white ethnic groups. J Natl Cancer Inst (2008) 2.64
Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. J Clin Oncol (2012) 2.34
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies. Thromb J (2013) 2.21
Estimating Optimal Treatment Regimes from a Classification Perspective. Stat (2012) 1.95
Divergent cancer pathways for early-onset and late-onset cutaneous malignant melanoma. Cancer (2009) 1.71
Effect of epidural anesthesia and analgesia on perioperative outcome: a randomized, controlled Veterans Affairs cooperative study. Ann Surg (2001) 1.69
A generalized estimator of the attributable benefit of an optimal treatment regime. Biometrics (2009) 1.58
Variable Selection for Qualitative Interactions. Stat Methodol (2011) 1.52
Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States. Cancer Epidemiol Biomarkers Prev (2009) 1.40
Interaction trees with censored survival data. Int J Biostat (2008) 1.31
Gene-environment interactions in cancer epidemiology: a National Cancer Institute Think Tank report. Genet Epidemiol (2013) 1.27
STAR 3 randomized controlled trial to compare sensor-augmented insulin pump therapy with multiple daily injections in the treatment of type 1 diabetes: research design, methods, and baseline characteristics of enrolled subjects. Diabetes Technol Ther (2010) 1.23
An approach to evaluating and comparing biomarkers for patient treatment selection. Int J Biostat (2014) 1.18
Variable selection for qualitative interactions in personalized medicine while controlling the family-wise error rate. J Biopharm Stat (2011) 1.16
Qualitative age interactions in breast cancer studies: mind the gap. J Clin Oncol (2009) 1.12
Detecting moderator effects using subgroup analyses. Prev Sci (2013) 1.11
Analyzing longitudinal data to characterize the accuracy of markers used to select treatment. Stat Med (2014) 1.10
Estimation of treatment policies based on functional predictors. Stat Sin (2014) 0.96
Treatment Heterogeneity and Individual Qualitative Interaction. Am Stat (2012) 0.93
'Lost in translation': accounting for between-country differences in the analysis of multinational cost-effectiveness data. Pharmacoeconomics (2006) 0.93
Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion. Leukemia (2015) 0.88
On Bayesian methods of exploring qualitative interactions for targeted treatment. Stat Med (2012) 0.88
Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: results of the ALFA-0701 trial. Oncotarget (2014) 0.87
Open-label, randomized, comparative, phase III study on effects of reducing steroid use in combination with Palonosetron. Cancer Sci (2015) 0.86
Effectiveness of chest physiotherapy in infants hospitalized with acute bronchiolitis: a multicenter, randomized, controlled trial. PLoS Med (2010) 0.85
Using decision lists to construct interpretable and parsimonious treatment regimes. Biometrics (2015) 0.82
Assessing the heterogeneity of treatment effects via potential outcomes of individual patients. J R Stat Soc Ser C Appl Stat (2013) 0.82
Effect of lenalidomide treatment on clonal architecture of myelodysplastic syndromes without 5q deletion. Blood (2015) 0.82
On Sparse representation for Optimal Individualized Treatment Selection with Penalized Outcome Weighted Learning. Stat (2015) 0.82
Monitoring futility in a two-by-two factorial design: the SPS3 experience. Clin Trials (2013) 0.78
Statistical interactions and Bayes estimation of log odds in case-control studies. Stat Methods Med Res (2015) 0.78
Estimating the range of obesity treatment response variability in humans: methods and illustrations. Hum Hered (2013) 0.78
Subgroup Identification in Personalized Treatment of Alcohol Dependence. Alcohol Clin Exp Res (2015) 0.78
Quantifying Treatment Benefit in Molecular Subgroups to Assess a Predictive Biomarker. Clin Cancer Res (2016) 0.78
Mortality in the randomized, controlled lung intergroup trial of isotretinoin. Cancer Prev Res (Phila) (2010) 0.76
Sequential advantage selection for optimal treatment regime. Ann Appl Stat (2016) 0.75
Penalized regression procedures for variable selection in the potential outcomes framework. Stat Med (2015) 0.75
The Use of Covariates and Random Effects in Evaluating Predictive Biomarkers Under a Potential Outcome Framework. Ann Appl Stat (2014) 0.75
Generated effect modifiers (GEM's) in randomized clinical trials. Biostatistics (2016) 0.75
Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment. J Alzheimers Dis (2016) 0.75
Differential effects of perceived stress on alcohol consumption in moderate versus heavy drinking HIV-infected women. Drug Alcohol Depend (2017) 0.75
Beyond Correlations, Sensitivities, and Specificities: A Roadmap for Demonstrating Utility of Advanced Imaging in Oncology Treatment and Clinical Trial Design. Acad Radiol (2017) 0.75
Neither pre-operative education or a minimally invasive procedure have any influence on the recovery time after total hip replacement. Int Orthop (2015) 0.75
Safety and efficacy of Cerebrolysin in motor function recovery after stroke: a meta-analysis of the CARS trials. Neurol Sci (2017) 0.75
Gene-expression profiles in hereditary breast cancer. N Engl J Med (2001) 29.80
Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics (1975) 18.25
Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature (2000) 15.53
Flexible regression models with cubic splines. Stat Med (1989) 14.45
The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 9.40
Signaling of cell fate decisions by CLAVATA3 in Arabidopsis shoot meristems. Science (1999) 8.61
Data management and analysis for gene expression arrays. Nat Genet (1998) 8.60
Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst (1993) 8.30
The CONSTANS gene of Arabidopsis promotes flowering and encodes a protein showing similarities to zinc finger transcription factors. Cell (1995) 7.76
Dependence of stem cell fate in Arabidopsis on a feedback loop regulated by CLV3 activity. Science (2000) 6.05
Plasmid vectors for the genetic analysis and manipulation of rhizobia and other gram-negative bacteria. Methods Enzymol (1986) 5.58
High frequency mobilization of gram-negative bacterial replicons by the in vitro constructed Tn5-Mob transposon. Mol Gen Genet (1984) 5.35
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol (1996) 5.09
Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med (2001) 4.83
Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res (1998) 4.68
The potential for improved teamwork to reduce medical errors in the emergency department. The MedTeams Research Consortium. Ann Emerg Med (1999) 4.59
Trends in reported incidence of primary malignant brain tumors in children in the United States. J Natl Cancer Inst (1998) 4.32
Statistical aspects of prognostic factor studies in oncology. Br J Cancer (1994) 4.22
Bayesian variable selection method for censored survival data. Biometrics (1998) 3.84
A molecular link between stem cell regulation and floral patterning in Arabidopsis. Cell (2001) 3.55
Sample size requirements for evaluating a conservative therapy. Cancer Treat Rep (1978) 3.38
Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery (1986) 3.22
Randomized phase II clinical trials. Cancer Treat Rep (1985) 3.19
A model to select chemotherapy regimens for phase III trials for extensive-stage small-cell lung cancer. J Natl Cancer Inst (2000) 2.95
A new family of RSF1010-derived expression and lac-fusion broad-host-range vectors for gram-negative bacteria. Gene (1990) 2.89
Clinical trial designs for cytostatic agents: are new approaches needed? J Clin Oncol (2001) 2.82
Demonstration of high-fidelity simulation team training for emergency medicine. Acad Emerg Med (1999) 2.82
Extension of the host range of Escherichia coli vectors by incorporation of RSF1010 replication and mobilization functions. J Bacteriol (1985) 2.70
Simulation based teamwork training for emergency department staff: does it improve clinical team performance when added to an existing didactic teamwork curriculum? Qual Saf Health Care (2004) 2.60
Confidence intervals for reporting results of clinical trials. Ann Intern Med (1986) 2.49
Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. Br J Cancer (2006) 2.45
A review and critique of some models used in competing risk analysis. Biometrics (1975) 2.44
High-frequency conjugal plasmid transfer from gram-negative Escherichia coli to various gram-positive coryneform bacteria. J Bacteriol (1990) 2.42
The Comprehensive assessment and Referral Evaluation (CARE)--rationale, development and reliability. Int J Aging Hum Dev (1977) 2.35
The development of plasmid-free strains of Agrobacterium tumefaciens by using incompatibility with a Rhizobium meliloti plasmid to eliminate pAtC58. Plasmid (1985) 2.33
A possible vulnerability locus for bipolar affective disorder on chromosome 21q22.3. Nat Genet (1994) 2.30
Repolarization dispersion and sudden cardiac death in patients with impaired left ventricular function. Eur Heart J (1997) 2.27
Length biased sampling in etiologic studies. Am J Epidemiol (1980) 2.23
Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways. J Pathol (1999) 2.22
Statistical model to determine the relationship of response and survival in patients with advanced ovarian cancer treated with chemotherapy. J Natl Cancer Inst (1992) 2.16
Efficacy of selected diagnostic tests for sexually transmitted diseases. JAMA (1976) 2.15
Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease. Nat Med (1999) 2.11
A non-parametric graphical representation of the relationship between survival and the occurrence of an event: application to responder versus non-responder bias. Stat Med (1984) 2.06
Measures of explained variation for survival data. Stat Med (1990) 2.06
Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993--the perspective of NIH clinical trialists. Control Clin Trials (1995) 2.04
Geographic variation in mortality from breast cancer among white women in the United States. J Natl Cancer Inst (1995) 2.03
On the efficiency of targeted clinical trials. Stat Med (2005) 1.99
Practical Bayesian guidelines for phase IIB clinical trials. Biometrics (1994) 1.99
Therapeutic response in phase I trials of antineoplastic agents. Cancer Treat Rep (1986) 1.91
Influence of doxorubicin dose intensity on response and outcome for patients with osteogenic sarcoma and Ewing's sarcoma. J Natl Cancer Inst (1991) 1.85
Tumor size, sensitivity to therapy, and design of treatment schedules. Cancer Treat Rep (1977) 1.82
Evidence that childhood acute lymphoblastic leukemia is associated with an infectious agent linked to hygiene conditions. Cancer Causes Control (1998) 1.78
Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progress. J Clin Oncol (1999) 1.77
Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Pathol (1999) 1.76
Assessing whether to perform a confirmatory randomized clinical trial. J Natl Cancer Inst (1996) 1.76
Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma. J Clin Oncol (1998) 1.71
A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy. Cancer (1978) 1.71
The Norton-Simon hypothesis revisited. Cancer Treat Rep (1986) 1.70
Genetics of xanthan production in Xanthomonas campestris: the xanA and xanB genes are involved in UDP-glucose and GDP-mannose biosynthesis. J Bacteriol (1992) 1.68
Statistical design of reverse dye microarrays. Bioinformatics (2003) 1.68
Importance of multiagent chemotherapy regimens in ovarian carcinoma: dose intensity analysis. J Natl Cancer Inst (1993) 1.66
Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma. Oncogene (2007) 1.63
High incidence of anal cancer among AIDS patients. The AIDS/Cancer Working Group. Lancet (1994) 1.62
Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia. N Engl J Med (1973) 1.61
Parallels between UNUSUAL FLORAL ORGANS and FIMBRIATA, genes controlling flower development in Arabidopsis and Antirrhinum. Plant Cell (1995) 1.60
Role of independent data-monitoring committees in randomized clinical trials sponsored by the National Cancer Institute. J Clin Oncol (1997) 1.56
Bypass surgery versus stenting for the treatment of multivessel disease in patients with unstable angina compared with stable angina. Circulation (2002) 1.56
The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer. N Engl J Med (1978) 1.54
Total occlusion trial with angioplasty by using laser guidewire. The TOTAL trial. Eur Heart J (2000) 1.54
Why predictive indexes perform less well in validation studies. Is it magic or methods? Arch Intern Med (1987) 1.51
Comparison of microarray designs for class comparison and class discovery. Bioinformatics (2002) 1.51
Exercise-induced myocardial ischemia in isolated coronary artery ectasias and aneurysms ("dilated coronopathy"). J Am Coll Cardiol (1999) 1.50
Bayesian subset analysis. Biometrics (1991) 1.50
Percutaneous transluminal therapy of occluded saphenous vein grafts: can the challenge be met with ultrasound thrombolysis? Circulation (1999) 1.50
Are placebo-controlled clinical trials ethical or needed when alternative treatment exists? Ann Intern Med (2000) 1.47
A simulation study of cross-validation for selecting an optimal cutpoint in univariate survival analysis. Stat Med (1996) 1.44
Selecting an efficient design for assessing exposure-disease relationships in an assembled cohort. Biometrics (1991) 1.44
Carvedilol for prevention of restenosis after directional coronary atherectomy : final results of the European carvedilol atherectomy restenosis (EUROCARE) trial. Circulation (2000) 1.43
Identification of Rhizobium plasmid sequences involved in recognition of Psophocarpus, Vigna, and other legumes. J Cell Biol (1986) 1.41
Bicaval versus atrial anastomoses in cardiac transplantation. Right atrial dimension and tricuspid valve function at rest and during exercise up to thirty-six months after transplantation. J Thorac Cardiovasc Surg (1994) 1.41
Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer. Br J Cancer (2009) 1.40
Predicting the course of Gompertzian growth. Nature (1976) 1.39
Restricted randomization designs in clinical trials. Biometrics (1979) 1.38
Dual role for fimbriata in regulating floral homeotic genes and cell division in Antirrhinum. EMBO J (1997) 1.38
Methodologic guidelines for reports of clinical trials. Cancer Treat Rep (1985) 1.38
Estimation of tamoxifen's efficacy for preventing the formation and growth of breast tumors. J Natl Cancer Inst (2000) 1.37
Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer. Cancer Res (1979) 1.35
Length and loss of heterozygosity of an intron 1 polymorphic sequence of egfr is related to cytogenetic alterations and epithelial growth factor receptor expression. Cancer Res (2000) 1.35
Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Mol Pathol (2000) 1.34
Transmission of HTLV-I and HIV among homosexual men in Trinidad. JAMA (1987) 1.31
KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancer. Oncogene (2006) 1.29
Prognostic factors in Burkitt's lymphoma: importance of total tumor burden. Cancer (1980) 1.29
Prolonged disease-free survival in Hodgkin's disease with MOPP reinduction after first relapse. Ann Intern Med (1979) 1.28
Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg (1985) 1.27
Long-term second remissions in acute lymphatic leukemia. Cancer (1975) 1.27
Association between steroid hormone receptor status and disease-free interval in breast cancer. Cancer Treat Rep (1979) 1.27
Type IV collagen immunoreactivity in colorectal cancer. Prognostic value of basement membrane deposition. Cancer (1988) 1.26
Cloning and analysis of a 35.3-kilobase DNA region involved in exopolysaccharide production by Xanthomonas campestris pv. campestris. J Bacteriol (1990) 1.26
Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution. J Pathol (2001) 1.26
High tibial osteotomy and ligament reconstruction in varus angulated, anterior cruciate ligament-deficient knees. A two- to seven-year follow-up study. Am J Sports Med (1993) 1.24